Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Letter to the EditorInfectious disease Open Access | 10.1172/JCI188895

The role of TREM2 in sepsis

Jiejie Zhu,1 Tianyin Sun,2 and Hanren Dai2

1Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei City, Anhui Province, China.

2School of Pharmacy, Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.

Address correspondence to: Hanren Dai, Anhui Medical University, Hefei, Anhui Province, China. Email: daihanren@126.com.

Find articles by Zhu, J. in: PubMed | Google Scholar

1Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei City, Anhui Province, China.

2School of Pharmacy, Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.

Address correspondence to: Hanren Dai, Anhui Medical University, Hefei, Anhui Province, China. Email: daihanren@126.com.

Find articles by Sun, T. in: PubMed | Google Scholar

1Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei City, Anhui Province, China.

2School of Pharmacy, Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.

Address correspondence to: Hanren Dai, Anhui Medical University, Hefei, Anhui Province, China. Email: daihanren@126.com.

Find articles by Dai, H. in: PubMed | Google Scholar

Published February 17, 2025 - More info

Published in Volume 135, Issue 4 on February 17, 2025
J Clin Invest. 2025;135(4):e188895. https://doi.org/10.1172/JCI188895.
© 2025 Zhu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published February 17, 2025 - Version history
View PDF

Related articles:

TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis
Siqi Ming, … , Xi Huang, Yongjian Wu
Siqi Ming, … , Xi Huang, Yongjian Wu
TREM2 aggravates sepsis by inhibiting macrophage fatty acid oxidation via SHP1-BTK axis
Research Article Infectious disease

TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis

  • Text
  • PDF
Abstract

Impaired fatty acid oxidation (FAO) and the therapeutic benefits of FAO restoration have been revealed in sepsis. However, the regulatory factors contributing to FAO dysfunction during sepsis remain inadequately clarified. In this study, we identified a subset of lipid-associated macrophages characterized by high expression of trigger receptor expressed on myeloid cells 2 (TREM2) and demonstrated that TREM2 acted as a suppressor of FAO to increase the susceptibility to sepsis. TREM2 expression was markedly upregulated in sepsis patients and correlated with the severity of sepsis. Knockout of TREM2 in macrophages improved the survival rate and reduced inflammation and organ injuries of sepsis mice. Notably, TREM2-deficient mice exhibited decreased triglyceride accumulation and an enhanced FAO rate. Further observations showed that the blockade of FAO substantially abolished the alleviated symptoms observed in TREM2-knockout mice. Mechanically, we demonstrated that TREM2 interacted with the phosphatase SHP1 to inhibit bruton tyrosine kinase–mediated (BTK-mediated) FAO in sepsis. Our findings expand the understanding of FAO dysfunction in sepsis and reveal TREM2 as a critical regulator of FAO that may provide a promising target for the clinical treatment of sepsis.

Authors

Siqi Ming, Xingyu Li, Qiang Xiao, Siying Qu, Qiaohua Wang, Qiongyan Fang, Pingping Liang, Yating Xu, Jingwen Yang, Yongqiang Yang, Xi Huang, Yongjian Wu

×
The role of TREM2 in sepsis. Reply.
Siqi Ming, … , Xi Huang, Yongjian Wu
Siqi Ming, … , Xi Huang, Yongjian Wu
Letter to the Editor Inflammation

The role of TREM2 in sepsis. Reply.

  • Text
  • PDF
Abstract

Authors

Siqi Ming, Xingyu Li, Jingxian Shu, Xi Huang, Yongjian Wu

×

To the editor: Sepsis is a major health problem that is characterized by a documented infection and systemic inflammatory response (1). We read with great interest the recent article by Ming et al. (2), wherein the authors revealed the role of TREM2 in aggravating sepsis by inhibiting fatty acid oxidation, which may provide a therapeutic target for sepsis manipulation. In this study, Ming et al. used wild-type (WT) and TREM2-knockout (TREM2–/–) mice to establish mouse models of sepsis induced by cecal ligation and puncture (CLP). The authors found that TREM2 knockout improved the survival rates and reduced the levels of inflammation and organ injuries in the CLP model.

However, we have some concerns about their data and conclusions. We found that their findings were contradictory to the study by Zhang et al. published in Nature Metabolism (3). Zhang et al. also employed WT and TREM2−/− mice to establish a CLP-induced mouse model of sepsis. The TREM2−/− mice used in these two studies were both provided by Prof. Marco Colonna (Washington University, St. Louis, Missouri, USA). Zhang et al. analyzed the survival of WT (n = 18) and TREM2−/− (n = 30) mice after CLP, and found that the mortality of TREM2−/− septic mice was notably increased and the levels of proinflammatory mediators were higher after CLP. However, we could not ascertain the number of surviving mice reported by Ming et al., and all the WT mice were apparently dead 72 hours after CLP challenge. Moreover, experiments detecting lung injuries and inflammatory cell infiltration were focused on a limited number (n = 5) of animals in each group, while the research by Zhang et al. was based on a larger number of mice.

Footnotes

Conflict of interest: The authors have declared that no conflict of interest exists.

Reference information: J. Clin. Invest. 2023;133(19):e188895. https://doi.org/10.1172/JCI188895.

See the related letter at The role of TREM2 in sepsis. Reply..

See the related letter at TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis.

References
  1. Huttunen R, Aittoniemi J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect. 2011;63(6):407–419.
    View this article via: CrossRef PubMed Google Scholar
  2. Ming S, et al. TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis. J Clin Invest. 2025;135(1):e159400.
    View this article via: JCI CrossRef PubMed Google Scholar
  3. Zhang K, et al. TREM2hi resident macrophages protect the septic heart by maintaining cardiomyocyte homeostasis. Nat Metab. 2023;5(1):129–146.
    View this article via: CrossRef PubMed Google Scholar
Version history
  • Version 1 (February 17, 2025): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts